Distinct mechanisms of resistance to fulvestrant treatment dictate level of ER independence and selective response to CDK inhibitors in metastatic breast cancer
氟维司群治疗耐药的不同机制决定了转移性乳腺癌中 ER 独立性水平和对 CDK 抑制剂的选择性反应
期刊:Breast Cancer Research
影响因子:6.1
doi:10.1186/s13058-021-01402-1
Kamila Kaminska #, Nina Akrap #, Johan Staaf, Carla L Alves, Anna Ehinger, Anna Ebbesson, Ingrid Hedenfalk, Lukas Beumers, Srinivas Veerla, Katja Harbst, Sidse Ehmsen, Signe Borgquist, Åke Borg, Alejandro Pérez-Fidalgo, Henrik J Ditzel, Ana Bosch #, Gabriella Honeth #
